Question Bank › Young streak off a low base

Young streak off a low base

Young streak off a low base: a short run of consecutive-period improvement has just started, after a stretch that gave i

Calls Tested
488
Answered YES
29
Hit Rate
5.9%
rare by design

Surgery Partners, Inc. (SGRY) — this company's answers

NO on the Q2 2022 call 2022-08-02 B+
The model's full reasoning — Q2 2022 call → NO我们根据提供的财报电话会议记录来判断。问题要求判断管理层是否传达了这样一个故事:业务现在已经有了一段短暂但连续的改善期(大约2到4个连续时期),而在此之前,业务曾表现不佳,且这种改善的原因与公司自身有关并且仍然有效。 我们需要检查管理层是否明确提到了连续的改善期,而非仅仅与去年同期比较。从记录中,管理层多次提到第二季度结果良好,并且强调了同比和环比增长。例如,Eric Evans说“我们继续看到我们的有机增长举措、加上过去一年完成的收购,转化为13%以上的强劲营收增长。”Wayne DeVeydt提到“我们以强劲的势头结束了本季度”。但问题要求“连续的几个时期,每个时期都比前一个更好”,并且要有“先前一段不令人印象深刻的时期”。管理层是否明确提到了连续的季度改善?他们提到了第一季度和上半年的结果,但电话会议主要聚焦第二季度。他们提到“我们确认了2022年全年指引”,但未明确说“这是连续第三个季度改善”之类的。他们提到“我们很高兴报告第二季度调整后EBITDA为8610万美元,同比增长13%”,但那是同比。他们提到“同一设施收入增长6.9%”,也是同比。他们没有明确说“每个季度都比上一个季度好”的序列。他们提到了“我们以强劲的势头结束了本季度”,但未具体说连续几个季度。 此外,他们提到了“我们继续看到我们的有机增长举措……转化为强劲的营收增长”,但未明确说是连续改善。他们提到“我们对我们在今年上半年取得的成果感到满意”,但未明确说这是从之前不佳状态转变。 关于先前不佳的时期,管理层提到了疫情的影响,但未明确说之前业务疲软。实际上,他们提到“我们继续应对COVID-19变种”,但整体在增长。所以可能不符合“先前一段不令人印象深刻的时期”。 另外,问题要求“改善是连续的、累积的”,但管理层没有明确说“连续几个季度”。他们只提到了第二季度和上半年,但没有说第二季度比第一季度好(实际上,第一季度EBITDA是多少?记录中未给出,但管理层提到了“第一季度我们已经上调了指引”,但未明确说连续改善)。 因此,基于严格标准,管理层没有明确描述一个从先前不佳状态转变而来的连续改善序列。他们只是报告了强劲的第二季度和同比强劲增长。他们没有提到“连续第三个季度”之类的语言。所以答案应为NO。 但是,我们再看一下,管理层提到“我们以强劲的势头结束了本季度”,并且“我们继续看到我们的有机增长举措……”,但这也可能是对现状的描述。没有明确说“连续”。 因此,我认为答案是否定的。

← Back to the full SGRY analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management convey that the business has NOW PUT TOGETHER A SHORT, STILL-YOUNG RUN OF CONSECUTIVE PERIODS OF REAL IMPROVEMENT \u2014 roughly two to four periods in a row of getting better \u2014 in a part of the business that, until recently, had been giving investors little reason to expect it, AND that the causes of this young run are attached to the company itself and still in force?\n\nAnswer YES when management's own words convey, in whatever form fits the business, ONE coherent story with all three of the following present:\n\n(1) A PRIOR STRETCH THAT WAS UNIMPRESSIVE, AND A RUN THAT IS STILL YOUNG. It is evident from management's own account that before this run began, the relevant part of the business \u2014 or the company as a whole \u2014 had been weak, flat, declining, stalled, unprofitable, or simply not yet performing: a stretch that would have given an outside observer little basis for optimism. Against that backdrop, management now describes a recent succession of periods \u2014 the just-reported period plus one or more immediately before it \u2014 in which things have gotten better each time: for example, orders, sales, volumes, customers, utilization, output, activity, or profitability improving quarter after quarter for the last few quarters; losses narrowing period by period; a recovery or ramp that has now strung together several consecutive periods of progress; or management noting that this is the second, third, or fourth period in a row of improvement. The run must be YOUNG \u2014 recent enough that management still frames it as a change from what came before, not a long-established record \u2014 and it must be grounded in real, already-occurred results in management's own telling, not in guidance or hopes.\n\n(2) THE IMPROVEMENT IS SEQUENTIAL AND CUMULATIVE IN MANAGEMENT'S OWN FRAMING. Management itself connects the recent periods into one building progression \u2014 each period better than, or building on, the one before \u2014 rather than merely comparing against a year-ago period or describing one good quarter in isolation. The form of the linkage may vary (consecutive-quarter language, month-after-month or period-after-period progression, a count of successive improvements, or a plainly described step-by-step climb), so long as the sequence is management's own account of what has already happened.\n\n(3) THE CAUSE BELONGS TO THE COMPANY AND IS STILL RUNNING. When management explains why the run exists, the explanation rests mainly on things attached to the company itself \u2014 a product or offering now selling, customers won or returning, a fix, change, capability, or capacity the company put in place now working, execution or positioning the company improved \u2014 rather than on commodity prices, industry-wide tailwinds, restocking, or one-time events; AND management conveys, directly or plainly in substance, that these same drivers remain in effect now, so the just-reported period is presented as the latest step of something still climbing rather than the end of a bounce.\n\nAnswer NO if the company has been performing well for a long time, so the recent periods are simply continuation of an established good record rather than a young change from an unimpressive stretch. NO if the call describes only one good or improved period with no succession of consecutive periods behind it. NO if the improvement is only against the year-ago period, only in guidance, or only expected rather than already strung together in reported periods. NO if management attributes the run mainly to external forces \u2014 commodity or market prices, industry recovery, weather, restocking, pull-forward, an easy comparison \u2014 or to one-time items or cost cuts on a shrinking business. NO if management itself presents the run as finished, peaking, or likely to pause. NO if the business is still deteriorating, with improvement only promised. NO if the sequential framing appears only in an analyst's question or model that management does not itself affirm.\n\nUse only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
ASO Academy Sports and Outdoors, Inc. Q1 2024 2024-06-11 C+
WRBY Warby Parker Inc. Q1 2024 2024-05-09 A
ASB Associated Banc-Corp Q1 2024 2024-04-25 A
KOPN Kopin Corporation Q4 2023 2024-03-14 C+
OLPX Olaplex Holdings, Inc. Q4 2023 2024-02-29 D
MNKD MannKind Corporation Q4 2023 2024-02-27 C
GPRE Green Plains Inc. Q4 2023 2024-02-07 F
SCPH scPharmaceuticals Inc. Q3 2023 2023-11-08 B
BMBL Bumble Inc. Q3 2023 2023-11-07 F
ALL The Allstate Corporation Q3 2023 2023-11-02 C+
GOLD Barrick Gold Corporation Q3 2023 2023-11-02 C
OPAD Offerpad Solutions Inc. Q3 2023 2023-11-01 C
TEL TE Connectivity Ltd. Q4 2023 2023-11-01 B
SBRA Sabra Health Care REIT, Inc. Q1 2023 2023-05-04 B
TACT TransAct Technologies Incorporated Q4 2022 2023-03-08 A
TOST Toast, Inc. Q4 2022 2023-02-16 C+
PKOH Park-Ohio Holdings Corp. Q3 2022 2022-11-13 B
SIBN SI-BONE, Inc. Q3 2022 2022-11-07 C+
OGI OrganiGram Holdings Inc. Q3 2022 2022-07-14 B+
BXP Boston Properties, Inc. Q1 2022 2022-05-03 A
LC LendingClub Corporation Q4 2021 2022-01-26 A
LEG Leggett & Platt, Incorporated Q3 2021 2021-11-02 C
UFI Unifi, Inc. Q4 2021 2021-08-07 B
ESRT Empire State Realty Trust, Inc. Q2 2021 2021-07-29 C+
LRN Stride, Inc. Q1 2019 2018-10-23 B
ORAN Orange SA Q2 2018 2018-07-26 B
AVT Avnet, Inc. Q2 2018 2018-01-25 B
HOLX Hologic, Inc. Q4 2017 2017-11-08 D
SPR Spirit AeroSystems Holdings, Inc. Q1 2016 2016-04-29 D

How the model reasoned

WRBY · Q1 2024 → YESThe question is about whether management conveys a short, still-young run of consecutive periods of real improvement in a part of the business that was previously unimpressive, caused by company-speci...
ASB · Q1 2024 → YESThe question is about whether management conveys a short, still-young run of consecutive periods of real improvement in a part of the business that was previously unimpressive, caused by company-speci...
KOPN · Q4 2023 → YESThe question is about whether management conveys a short, still-young run of consecutive periods of real improvement in a part of the business that was previously unimpressive, caused by company-speci...

More from the question bank

Still getting better as they speakSold out of itselfThe hard part is already doneSecond demand front open and fundedFront, middle, and back of the business all Someone else's clock has started running agaAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.